30

Pharmaron Beijing Co LtdSHE 300759 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

4.575

Middle

Exchange

XSHE - Shenzhen Stock Exchange

300759.SZ Stock Analysis

30

Uncovered

Pharmaron Beijing Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

4.575

Dividend yield

2.07 %

Shares outstanding

1 190.11 B

Pharmaron Beijing Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 14,923 full-time employees. The company went IPO on 2019-01-28. Pharmaron Beijing Co Ltd is a China-based company providing research and manufacturing service portfolio, medical tools and clinical research testing services in the process of discovering, developing and manufacturing small molecule drugs, cell therapy and gene therapy. The firm operates in four segments. Laboratory Services segment includes laboratory chemistry, drug metabolism and pharmacokinetics/absorption, distribution, metabolism and excretion, biology, safety assessment and discovery of biological agents. CMC Service segment is engaged in process development and preform production and analysis. Clinical Development Service segment includes clinical research, on-site management organization, regulatory biological analysis and radioactive labeling scientific services. The Biologics and CGT Services segment is engaged in the discovery, development and production of macromolecular drugs, development of cell gene therapy methods and other businesses.

View Section: Eyestock Rating